US5571500A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
US5869054A
(en)
*
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
US5571499A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5641474A
(en)
*
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
US5645820A
(en)
*
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US6113903A
(en)
*
|
1989-03-21 |
2000-09-05 |
The Immune Response Corporation |
Peptides and methods against diabetes
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US5891435A
(en)
*
|
1993-04-16 |
1999-04-06 |
Research Corporation Technologies, Inc. |
Methods and compositions for delaying or preventing the onset of autoimmune disease
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US6794357B1
(en)
*
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
GB9319429D0
(en)
*
|
1993-09-21 |
1993-11-03 |
London Health Ass |
Methods and products for controlling immune responses in mammals
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US6932962B1
(en)
|
1994-12-22 |
2005-08-23 |
Astrazeneca Ab |
Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
|
AU703532B2
(en)
|
1994-12-22 |
1999-03-25 |
Astra Aktiebolag |
Therapeutic preparation for inhalation containing parathyroid hormone, PTH
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
EP0835129B1
(en)
*
|
1995-06-30 |
2003-10-29 |
Novo Nordisk A/S |
Prevention of a disease having the characteristics of diabetes
|
US6488933B2
(en)
|
1995-07-05 |
2002-12-03 |
Yeda Research And Development Co. Ltd. |
Preparations for the treatment of T cell mediated diseases
|
US5856446A
(en)
*
|
1995-07-07 |
1999-01-05 |
Autoimmune Inc. |
Method of treating rheumatoid arthritis with low dose type II collagen
|
WO1997009061A1
(en)
*
|
1995-09-06 |
1997-03-13 |
Alexion Pharmaceuticals, Inc. |
Treatment of diabetes via administration of hormonally ineffective insulin
|
SE520392C2
(sv)
*
|
1996-09-27 |
2003-07-01 |
Creative Peptides Sweden Ab C |
Specifika peptider för behandling av diabetes mellitus
|
US20050025758A1
(en)
*
|
1996-10-01 |
2005-02-03 |
Harrison Leonard Charles |
Method and compositions for treatment of insulin-dependant diabetes mellitus
|
JP2001511187A
(ja)
*
|
1997-02-28 |
2001-08-07 |
エンゾー セラピュウティクス, インコーポレイテッド |
選択的免疫ダウンレギュレーション(sidr)を行う新規プロセス
|
US5948407A
(en)
*
|
1997-03-19 |
1999-09-07 |
Shire Laboratories Inc. |
Oral induction of tolerance to parenterally administered non-autologous polypeptides
|
DE19733651A1
(de)
*
|
1997-08-04 |
1999-02-18 |
Boehringer Ingelheim Pharma |
Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
|
US20060239930A1
(en)
*
|
1997-08-04 |
2006-10-26 |
Herbert Lamche |
Process for nebulizing aqueous compositions containing highly concentrated insulin
|
US6068844A
(en)
*
|
1997-12-19 |
2000-05-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof
|
US20040062802A1
(en)
*
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6417208B1
(en)
*
|
1999-02-05 |
2002-07-09 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of identification of inhibitors of PDE1C
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2274414A1
(en)
*
|
1999-06-11 |
2000-12-11 |
Universite Laval |
Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
|
DK1196430T3
(da)
*
|
1999-06-29 |
2012-05-21 |
Mannkind Corp |
Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
US7166280B2
(en)
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US6543682B1
(en)
|
2000-05-03 |
2003-04-08 |
Nichole Glaser |
Insulin-dose calculator disk
|
EP1286664B1
(en)
*
|
2000-05-12 |
2007-07-25 |
Oregon Health and Science University |
Combination of low dose estrogen and immunotherapeutic agent for treating immune diseases
|
US7462486B2
(en)
*
|
2000-05-12 |
2008-12-09 |
Oregon Health & Science University |
Methods of selecting T cell receptor V peptides for therapeutic use
|
ATE367823T1
(de)
|
2000-05-24 |
2007-08-15 |
Us Health |
E-selectin zur behandlung oder vorbeugung von schlaganfall
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
PL366398A1
(en)
*
|
2001-05-04 |
2005-01-24 |
Pfizer Products Inc. |
Method of preventing type 2 diabetes with aerosolized insulin
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US20030198666A1
(en)
*
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
CA2479751C
(en)
|
2002-03-20 |
2008-06-03 |
Trent Poole |
Inhalation apparatus
|
CA2524175C
(en)
*
|
2003-04-28 |
2016-06-14 |
Sankyo Company Limited |
Sugar intake-ability enhancer
|
ES2421520T3
(es)
*
|
2003-04-28 |
2013-09-03 |
Daiichi Sankyo Co Ltd |
Potenciador de la producción de adiponectina
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
JP2007517892A
(ja)
*
|
2004-01-12 |
2007-07-05 |
マンカインド コーポレイション |
2型糖尿病における血清プロインスリンレベルを低下させる方法
|
ES2328048T3
(es)
|
2004-03-12 |
2009-11-06 |
Biodel, Inc. |
Composiciones de insulina con absorcion mejorada.
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
JP5563735B2
(ja)
|
2004-06-16 |
2014-07-30 |
タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド |
Ppi多回剤形
|
NZ553263A
(en)
|
2004-07-19 |
2010-06-25 |
Biocon Ltd |
Insulin-oligomer conjugates, formulations and uses thereof
|
EP1786465A4
(en)
*
|
2004-07-30 |
2009-01-21 |
Univ Oregon Health & Science |
METHODS FOR DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
|
US7709639B2
(en)
|
2004-08-20 |
2010-05-04 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
ES2543007T3
(es)
|
2004-08-23 |
2015-08-13 |
Mannkind Corporation |
Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos
|
US20090068207A1
(en)
*
|
2005-04-15 |
2009-03-12 |
Vascular Biogenics Ltd. |
Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
|
WO2007033316A2
(en)
|
2005-09-14 |
2007-03-22 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
EP1931665A1
(en)
|
2005-09-20 |
2008-06-18 |
Schering Corporation |
1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-flu0r0-4-piperidinyl,]carbonyl]-4-[2-(2-pyridinyl)-3h-imidaz0[4, 5-b]pyridin-3-yl]piperidine useful as histamine h3 antagonist
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
EP1986679B1
(en)
|
2006-02-22 |
2017-10-25 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
WO2007121256A2
(en)
*
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
EP3050568B1
(en)
|
2007-03-13 |
2020-12-02 |
JDS Therapeutics, LLC |
Methods and compositions for the sustained release of chromium
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
KR20150084013A
(ko)
|
2007-10-12 |
2015-07-21 |
다케다 파마슈티칼스 유에스에이, 인코포레이티드 |
음식 섭취와 관계없이 위장 장애를 치료하는 방법
|
US9241908B2
(en)
|
2007-10-16 |
2016-01-26 |
Biocon Limited |
Orally administrable solid pharmaceutical composition and a process thereof
|
CN101910151A
(zh)
|
2007-10-22 |
2010-12-08 |
先灵公司 |
双环杂环衍生物及其作为gpr119活性调节剂的用途
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
EP2234644B1
(en)
*
|
2008-01-04 |
2013-07-31 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
WO2009143049A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
AU2009256157B2
(en)
|
2008-06-04 |
2014-12-18 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
TWI611818B
(zh)
|
2008-06-13 |
2018-01-21 |
曼凱公司 |
用於藥物傳輸之乾粉吸入器及系統
|
CN103751892B
(zh)
|
2008-06-20 |
2017-03-01 |
曼金德公司 |
用于对吸入工作进行实时描绘的交互式设备和方法
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
JP2011528365A
(ja)
|
2008-07-16 |
2011-11-17 |
シェーリング コーポレイション |
Gpr119モジュレーターとしての二環式ヘテロ環誘導体およびそれらの使用方法
|
WO2010027567A2
(en)
|
2008-07-23 |
2010-03-11 |
Schering Corporation |
Tricyclic spirocycle derivatives and methods of use thereof
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
JP2012504630A
(ja)
|
2008-10-03 |
2012-02-23 |
シェーリング コーポレイション |
グルカゴン受容体アンタゴニストとしてのスピロイミダゾロン誘導体
|
JP2012505899A
(ja)
|
2008-10-16 |
2012-03-08 |
シェーリング コーポレイション |
アジン誘導体およびそれの使用方法
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
US8283360B2
(en)
|
2008-12-19 |
2012-10-09 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocyclic derivatives and methods of use thereof
|
US20110245267A1
(en)
|
2008-12-19 |
2011-10-06 |
Schering Plough Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
JP2012513470A
(ja)
|
2008-12-23 |
2012-06-14 |
シェーリング コーポレイション |
二環式複素環誘導体及びその使用方法
|
EP2382204B1
(en)
|
2008-12-23 |
2018-07-11 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
ES2791683T3
(es)
*
|
2009-01-28 |
2020-11-05 |
Smartcells Inc |
Sistemas a base de conjugados para la administración controlada de fármacos
|
WO2010092218A2
(es)
|
2009-02-12 |
2010-08-19 |
Proyecto De Biomedicina Cima, S.L. |
Uso de la cardiotrofina-1 para el tratamiento de enfermedades metabólicas
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
EP2676695A3
(en)
|
2009-03-11 |
2017-03-01 |
MannKind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
CA2755251A1
(en)
|
2009-03-18 |
2010-09-23 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
JP5670421B2
(ja)
|
2009-03-31 |
2015-02-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
コンポーネント表面のコーティング方法
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
US8580807B2
(en)
|
2009-04-03 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
WO2010144664A1
(en)
|
2009-06-12 |
2010-12-16 |
Schering Corporation |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
MY186975A
(en)
|
2009-06-12 |
2021-08-26 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
US20120172369A1
(en)
|
2009-09-14 |
2012-07-05 |
Ting Pauline C |
Inhibitors of diacylglycerol acyltransferase
|
US8759357B2
(en)
|
2009-10-08 |
2014-06-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (FABP)
|
US9409918B2
(en)
|
2009-10-29 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
US8912206B2
(en)
|
2009-11-23 |
2014-12-16 |
Merck Sharp & Dohme Corp. |
Pyrimidine ether derivatives and methods of use thereof
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
EP2503887B1
(en)
|
2009-11-24 |
2016-01-06 |
Merck Sharp & Dohme Corp. |
Substituted biaryl derivatives and methods of use thereof
|
JP5658268B2
(ja)
|
2009-11-25 |
2015-01-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
KR101782306B1
(ko)
|
2009-11-25 |
2017-09-27 |
베링거 인겔하임 인터내셔날 게엠베하 |
분무기
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
US9943654B2
(en)
|
2010-06-24 |
2018-04-17 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
AU2011282988A1
(en)
|
2010-07-28 |
2013-01-31 |
Smartcells, Inc. |
Recombinantly expressed insulin polypeptides and uses thereof
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8603527B2
(en)
|
2010-10-25 |
2013-12-10 |
Signal Pharmaceuticals, Llc |
Pharmaceutical formulations of a substituted diaminopurine
|
CN103702672B
(zh)
|
2011-03-01 |
2016-04-27 |
Jds治疗有限公司 |
用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物
|
WO2012130757A1
(de)
|
2011-04-01 |
2012-10-04 |
Boehringer Ingelheim International Gmbh |
Medizinisches gerät mit behälter
|
DK2694402T3
(en)
|
2011-04-01 |
2017-07-03 |
Mannkind Corp |
BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
ES2624294T3
(es)
|
2012-07-12 |
2017-07-13 |
Mannkind Corporation |
Sistemas de suministro de fármacos en polvo seco
|
WO2014057522A1
(en)
|
2012-10-12 |
2014-04-17 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
US10441560B2
(en)
|
2013-03-15 |
2019-10-15 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
JP6442412B2
(ja)
|
2013-03-15 |
2018-12-19 |
持田製薬株式会社 |
非アルコール性脂肪性肝炎治療のための組成物および方法
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
WO2014197720A2
(en)
|
2013-06-05 |
2014-12-11 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
KR102321339B1
(ko)
|
2013-07-18 |
2021-11-02 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
ES2836977T3
(es)
|
2013-08-09 |
2021-06-28 |
Boehringer Ingelheim Int |
Nebulizador
|
EP3030298B1
(en)
|
2013-08-09 |
2017-10-11 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
CA2924743A1
(en)
|
2013-10-04 |
2015-04-09 |
Merck Sharp & Dohme Corp. |
Glucose-responsive insulin conjugates
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
ES2954961T3
(es)
|
2014-05-07 |
2023-11-27 |
Boehringer Ingelheim Int |
Unidad, nebulizador y método
|
HUE055604T2
(hu)
|
2014-05-07 |
2021-12-28 |
Boehringer Ingelheim Int |
Porlasztó
|
KR102443739B1
(ko)
|
2014-05-07 |
2022-09-19 |
베링거 인겔하임 인터내셔날 게엠베하 |
분무기 및 컨테이너
|
RU2017104284A
(ru)
|
2014-07-15 |
2018-08-15 |
Йиссум Рисеч Девелопмент Компани Оф Зе Хебрю Юниверсити Оф Джерусалем Лтд. |
Выделенные полипептиды cd44 и их применение
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
CA2963639C
(en)
|
2014-10-06 |
2023-07-04 |
Signal Pharmaceuticals, Llc |
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
|
CA3018328A1
(en)
|
2014-10-31 |
2016-04-30 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
GB2564295A
(en)
|
2016-02-11 |
2019-01-09 |
Nutrition 21 Llc |
Chromium containing compositions for improving health and fitness
|
BR112018070163A2
(pt)
|
2016-04-01 |
2019-01-29 |
Signal Pharm Llc |
compostos de aminopurina substituída, composições e métodos de tratamento
|
PT3436019T
(pt)
|
2016-04-01 |
2021-11-04 |
Signal Pharm Llc |
(1s,4s)-4-(2-(((3s,4r)-3-fluorotetra-hidro-2h-piran-4- il)amino)-8-((2,4,6-triclorofenil)amino)-9h-purin-9-il)-1- metilciclo-hexano-1-carboxamida e métodos de utilização dos mesmos
|
MX2020003620A
(es)
|
2017-10-04 |
2020-10-28 |
Celgene Corp |
Composiciones y métodos para usar cis-4-[2-{[(3s,4r)-3-fluorooxan- 4-il]amino}-8-(2,4,6-tricloroanilino)-9h-purin-9-il]-1-etilcicloh exano-1-carboxamida.
|
CN111417634A
(zh)
|
2017-10-04 |
2020-07-14 |
细胞基因公司 |
用于制备顺式-4-[2-{[(3s,4r)-3-氟噁烷-4-基]氨基}-8-(2,4,6-三氯苯胺基)-9h-嘌呤-9-基]-1-甲基环己烷-1-甲酰胺的方法
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2023200363A1
(ru)
*
|
2022-04-13 |
2023-10-19 |
Фания Иршатовна МАГАНОВА |
Способ получения пероральной формы субстанции, содержащей инсулин
|